MOUSE - Mapping OUtcomes measured in pre-clinical Studies against randomised phase 3/4 Effectiveness trials. Do core outcome sets developed for phase3/4 effectiveness trials translate to pre-clinical research?


Harman, Nicola L ORCID: 0000-0001-6958-6466, Sanz-Moreno, Adrian, Ameen-Ali, Kamar E, Papoutsopoulou, Stamatia ORCID: 0000-0001-6665-8508, Lloyd, Katie, Garcia-Finana, Marta ORCID: 0000-0003-4939-0575, MacLeod, Malcolm and Williamson, Paula R ORCID: 0000-0001-9802-6636 (2019) MOUSE - Mapping OUtcomes measured in pre-clinical Studies against randomised phase 3/4 Effectiveness trials. Do core outcome sets developed for phase3/4 effectiveness trials translate to pre-clinical research? In: International Clinical Trials Methodology Conference, 2019-10-7 - 2019-10-9, Brighton.

[thumbnail of ICTMC animal studies V2.0 Submitted 4-5-19.docx] Text
ICTMC animal studies V2.0 Submitted 4-5-19.docx - Author Accepted Manuscript
Download (16kB)
Item Type: Conference or Workshop Item (Unspecified)
Depositing User: Symplectic Admin
Date Deposited: 21 Oct 2019 09:41
Last Modified: 19 Jan 2023 00:21
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3058926
Share
CORE (COnnecting REpositories)